Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Makris

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|April 28, 2009
Early breast cancerJohn R Benson, Ismail Jatoi, Martin Keisch, et al.
Journal of Ultrasound|June 23, 2023
Two-dimensional ultrasound results in underestimation of the ovarian follicle size compared to automated three-dimensional imaging in women undergoing IVFMiltiades A Kyprianou, Konstantina Dakou, George T Lainas, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 11, 2014
Therapy monitoring of skeletal metastases with whole-body diffusion MRIAnwar R Padhani, Andreas Makris, Peter Gall, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2017
The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancerMichael Kosmin, Andreas Makris, Priya V Joshi, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 25, 2014
FLT PET-CT in evaluation of treatment responseBal Sanghera, Wai Lup Wong, Luke I Sonoda, et al.
Molecular Cancer Therapeutics|October 5, 2013
Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expressionJaishree Bhosle, Konstantinos Kiakos, Andrew C G Porter, et al.
Journal of Comparative Effectiveness Research|August 29, 2025
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancerStephen Chia, Jie Li, Fei Ma, et al.
Breast Cancer Research : BCR|June 23, 2006
Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancerRussell Burcombe, George D Wilson, Mitch Dowsett, et al.
Radiology|March 18, 2006
Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical resultsAnwar R Padhani, Carmel Hayes, Laura Assersohn, et al.
Journal of Assisted Reproduction and Genetics|January 25, 2015
Morphokinetic parameters of early embryo development via time lapse monitoring and their effect on embryo selection and ICSI outcomes: a prospective cohort studyCharalampos Siristatidis, Maria Aggeliki Komitopoulou, Andreas Makris, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|April 28, 2009
Early breast cancerJohn R Benson, Ismail Jatoi, Martin Keisch, et al.
Journal of Ultrasound|June 23, 2023
Two-dimensional ultrasound results in underestimation of the ovarian follicle size compared to automated three-dimensional imaging in women undergoing IVFMiltiades A Kyprianou, Konstantina Dakou, George T Lainas, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 11, 2014
Therapy monitoring of skeletal metastases with whole-body diffusion MRIAnwar R Padhani, Andreas Makris, Peter Gall, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2017
The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancerMichael Kosmin, Andreas Makris, Priya V Joshi, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 25, 2014
FLT PET-CT in evaluation of treatment responseBal Sanghera, Wai Lup Wong, Luke I Sonoda, et al.
Molecular Cancer Therapeutics|October 5, 2013
Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expressionJaishree Bhosle, Konstantinos Kiakos, Andrew C G Porter, et al.
Journal of Comparative Effectiveness Research|August 29, 2025
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancerStephen Chia, Jie Li, Fei Ma, et al.
Breast Cancer Research : BCR|June 23, 2006
Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancerRussell Burcombe, George D Wilson, Mitch Dowsett, et al.
Radiology|March 18, 2006
Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical resultsAnwar R Padhani, Carmel Hayes, Laura Assersohn, et al.
Journal of Assisted Reproduction and Genetics|January 25, 2015
Morphokinetic parameters of early embryo development via time lapse monitoring and their effect on embryo selection and ICSI outcomes: a prospective cohort studyCharalampos Siristatidis, Maria Aggeliki Komitopoulou, Andreas Makris, et al.
Pageof 7